The results of the present study indicate a need for Quality Assurance (QA) programs to be undertaken to avert considerable cost and high patient doses. The results are useful to national and professional organizations and can be used as a baseline upon which future dose measurements may be compared.
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
This record was last updated on 07/04/2016 and may not reflect the most current and accurate biomedical/scientific data available from NLM.
The corresponding record at NLM can be accessed at https://www.ncbi.nlm.nih.gov/pubmed/20607998